NEWSpublisher 2007 :: AngloChinese Investments
SEARCH NEWS
date from:
date to:
company:
search for string:
NEWS SECTIONS
COMPANY GROUPS
TOP NEWS
» 23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products
» 15/03/2010 [Industry news]
Recordati S.p.A And Lee Pharmaceutical Announce Partnership For Zanidip(R) In China
» 26/10/2009 [Finance]
China Growth to Remain Fast in Fourth Quarter, Official Says
» 17/08/2009 [Industry news]
Chindex Posts Profit on Product Sales, Health Services
» 07/05/2010 [Industry news]
Hong Kong: Recall of all products manufactured by Quality Pharmaceutical Lab Ltd
COMPANY NEWS back to previous page show list
TOP NEWS
Wuxi Pharma Tech
»23/02/2010 [Industry news]
WuXi toxicology facility gets AAALAC accreditation

Wuxi Pharmatech said that its Suzhou non-clinical safety testing facility received full accreditation from the Association for the Assessment and Accreditation of Laboratory Animal Care International (AAALAC).

 
WuXi PharmaTech, a pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the US, said that its Suzhou non-clinical safety testing facility received full accreditation from the Association for the Assessment and Accreditation of Laboratory Animal Care International (AAALAC). AAALAC is a private, nonprofit organization that promotes the humane treatment of animals in science through voluntary accreditation and assessment programs. It evaluates all aspects of an animal care and use program, including institutional policies, animal husbandry, veterinary care and the physical plant. The company release noted that as a result of an extensive on-site evaluation, AAALAC determined that WuXi PharmaTech\'s facility meets the highest standards of animal care and research practices. Dr Ge Li, Chairman and Chief Executive Officer of WuXi PharmaTech, siad, “This accreditation continues to demonstrate WuXi\'s ability to provide our global customers with high quality service in a regulatory compliant environment. We believe that China will become a major market for non-clinical safety testing services over the next decade, and our company aims to become a leading provider of such services in China. At 314,000 square foot and 108 animal rooms, our Suzhou facility is the largest in China.”

AngloChinese Investments ltd.
Home | Company news | TOP 50 | Events | About us
C&F Bright Solutions ltd.